
Overview
Amplicon is a biotechnology company that specializes in developing diagnostic tests based on real-time PCR technology, utilizing data from DNA sequences. They provide precise and reliable diagnostic tests for infectious and genetic diseases in both humans and animals, and they also design, optimize, and validate molecular diagnostic assays. Additionally, they conduct a range of highly specialized molecular research studies.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Podczas Walnego Zgromadzenia Wspólników z dnia 28 maja 2025 r. Wspólnicy podjęli uchwałę, według której Spółka ulegnie likwidacji pomiędzy 1 września 2026r. a 31 grudnia 2026 r.
Filing timeliness
Financial statements were filed on time, on average 36 days early.
- 202512/07/2026
- 202405/06/2025
- 202317/06/2024
- 202205/07/2023
- 202121/06/2022
- 202029/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- PCR diagnostic kits
- Pathogen diagnostic panels
- DNA polymorphism analysis kits
- Genetic diagnostics
- Diagnostic kit design
Websites
- amplicon.plAmplicon – technologie oparte na sekwencji DNAWordPress 7.1ElementorNginx
Public procurement
6 tenders recorded as contractor, with a total value of $72,894.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 8, 2025 | Diagnostic tests II | $968$968 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy | |
| Jul 10, 2024 | Diagnostic tests III | $2,234$2,234 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy | |
| Mar 13, 2024 | Diagnostic tests I | $10,663$10,663 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Bydgoszczy |
The company is the contractor in 4 public sector contracts, worth USD 11.89k in total. They were signed with 3 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 5, 2026 | 1. AmpliTest KHV (Real Time PCR) - 100 determinations | $445.71 | Uniwersytet Gdański | |
| Sep 17, 2026 | Test kits for tick-borne diseases, | $2,161 | Wojewódzki Inspektorat Weterynarii w Gdańsku | |
| Aug 27, 2026 | Laboratory tests. | $7,158 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w Szczecinie |
Authorized Representatives
Manner of representation
In the case of a multi-member management board: the members of the management board act independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Janusz Krzysztof Piechota age 49 | 10 | $2,701.24 | 50% |
Małgorzata Piskozub age 44 | 10 | $2,701.24 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
13 public aid cases recorded, with a total value of $92,844.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 25, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $122$122 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jan 16, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $296$296 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 1, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $243$243 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-10-01 | Development and validation of a panel diagnostic test to assess the risk of developing dementia and implement a personalized pharmacological therapy method and an algorithm for interpreting results | $174.9K$174,913 | Regional Operational Programme for the Lower Silesian Voivodeship 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Farmabol sp. z o.o. | $374,904.90 | farmabol.pl | ||
| Vitrotest Europe sp. z o.o. | $233,350.77 | vitrotest.pl | ||
| Kosma Pharma Group sp. z o.o. | $198,964.09 | lpc37.pl | ||
| GMT Genomics S.A. | $89,076.86 | genomtec.com | ||
| Replicon sp. z o.o. | $50,379.75 | replicon.pl | ||
| Grupa Psychotronics sp. z o.o. | $27,307.51 | psychotronics.pl | ||
| Biotransplant Research sp. z o.o. | $22,953.29 | biotransplant.pl |
FAQ
Last updated: 2026-10-07
